MedTrace Logo

Bryophyllum Pinnatum Tea as a Novel Treatment for Recurrent Kidney Stone Formers

NCT06987084 · Status: ENROLLING_BY_INVITATION · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 25

Last updated 2025-05-23

No results posted yet for this study

Summary

The aim of this randomized placebo-controlled double-blind crossover clinical trial is to test the ability of a traditional tea made from the leaf of the Bryophyllum pinnatum (B. pinnatum) plant in decreasing urinary calcium content in patients with recurrent calcium-based kidney stones.

Conditions

  • Kidney Calculi
  • Calcium Oxalate Kidney Stones
  • Calcium Phosphate Kidney Stones

Interventions

COMBINATION_PRODUCT

Bryophyllum pinnatum tea

24 g of B. pinnatum leaves boiled in 250 mL of water for 61 minutes sweetened with 1/2 teaspoon of sugar

COMBINATION_PRODUCT

Placebo tea

250 mL of water boiled with 3 g of wheat-bran for 5 minutes sweetened with 1/2 teaspoon of sugar

Sponsors & Collaborators

  • Indra Gupta

    lead OTHER

Principal Investigators

  • Indra Gupta, MD · Research Institute at the McGill University Health Centre

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-11-07
Primary Completion
2025-12-31
Completion
2025-12-31

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06987084 on ClinicalTrials.gov